Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2022

Open Access 01-12-2022 | Behavioural Therapy | Research

Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial

Authors: Anne-Lise Juul Haugan, Anne Mari Sund, Susan Young, Per Hove Thomsen, Stian Lydersen, Torunn Stene Nøvik

Published in: BMC Psychiatry | Issue 1/2022

Login to get access

Abstract

Background

Cognitive behavioural therapy (CBT) is recommended for attention-deficit/hyperactivity-disorder (ADHD) in adolescents. However, all CBTs are not created equal, and the guidelines do not specify which CBT interventions are the most effective for this patient group. This study examines the efficacy of a group CBT without parent involvement as follow-up treatment compared to no additional CBT in adolescents with persistent and impairing ADHD symptoms after a short psychoeducational intervention and medical treatment.

Methods

The authors conducted a two-arm parallel randomized controlled trial in two child and adolescent mental health outpatient clinics in Norway. One hundred patients aged 14–18 years with a diagnosis of ADHD (66%) or subthreshold ADHD (34%) were randomized to either a 12-week group CBT program (N = 50) or a non-CBT control condition (N = 50). Assessments were made at admission to the clinic, two weeks before and two weeks after treatment. The primary outcomes were parent-, teacher- and self-ratings of ADHD symptoms (ADHD Rating Scale-IV), and the secondary outcomes were ratings of ADHD symptom severity, executive function, functional impairment, and emotional problems. Evaluators blinded to group allocation rated ADHD symptom severity with the Clinical Global Impression Scale for Severity (CGI-S) at baseline and post-treatment.

Results

Analyses using mixed-effects models showed no difference between the treatment arms from baseline to post treatment in primary and secondary outcomes.

Conclusions

Contrary to our hypothesis, we found no incremental treatment effect on the part of a group CBT as follow-up to psychoeducation and pharmacological treatment on ADHD symptoms and accompanying impairments. Limitations with the CBT was the large number and low dosage of treatment components, causing restricted time for practice. Unlike evidence-based, individualized targeted CBTs with parent involvement, a group CBT directed solely at the adolescents with no parent involvement does not appear effective for treating ADHD.

Trial registration

NCT02937142, 18/10/2016.
Appendix
Available only for authorised users
Literature
1.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders (5th edn.). 5th ed. Washington DC: American Psychiatric Publishing; 2013.
2.
Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Psy. 2006;45(2):192–202.CrossRef
3.
Bagwell CL, Molina BSG, Pelham WEJ, Hoza B. Attention-deficit hyperactivity disorder and problems in peer relations: predictions from childhood to adolescence. J Am Acad Child Adolesc Psychiatry. 2001;40(11):1285–92.PubMedCrossRef
4.
Reale L, Bartoli B, Cartabia M, Zanetti M, Costantino MA, Canevini MP, et al. Comorbidity prevalence and treatment outcome in children and adolescents with ADHD. Eur Child Adolesc Psychiatry. 2017;26(12):1443–57.PubMedCrossRef
5.
Cadman T, Findon J, Eklund H, Hayward H, Howley D, Cheung C, et al. Six-year follow-up study of combined type ADHD from childhood to young adulthood: predictors of functional impairment and comorbid symptoms. Eur Psychiatry. 2016;35:47–54.PubMedCrossRef
6.
Chan E, Fogler JM, Hammerness PG. Treatment of attention-deficit/hyperactivity disorder in adolescents: a systematic review. Jama. 2016;315(18):1997–2008.PubMedCrossRef
7.
Cortese S, Adamo N, Del Giovane C, Mohr-Jensen C, Hayes AJ, Carucci S, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727–38.PubMedPubMedCentralCrossRef
8.
Swanson JM, Arnold LE, Molina BSG, Sibley MH, Hechtman LT, Hinshaw SP, et al. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatry. 2017;58(6):663–78.PubMedPubMedCentralCrossRef
9.
McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, et al. Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry. 2009;194(3):273–7.PubMedCrossRef
10.
Molina BS, Hinshaw SP, Swanson JM, Arnold LE, Vitiello B, Jensen PS, et al. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009;48(5):484–500.PubMedPubMedCentralCrossRef
11.
Uchida M, Spencer TJ, Faraone SV, Biederman J. Adult outcome of ADHD: an overview of results from the MGH longitudinal family studies of Pediatrically and psychiatrically referred youth with and without ADHD of both sexes. J Atten Disord. 2018;22(6):523–34.PubMedCrossRef
12.
13.
14.
15.
Evans SW, Owens JS, Bunford N. Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol. 2014;43(4):527–51.PubMedCrossRef
16.
Sprich SE, Safren SA, Finkelstein D, Remmert JE, Hammerness P. A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents. J Child Psychol Psychiatry. 2016;57(11):1218–26.PubMedPubMedCentralCrossRef
17.
Sibley MH, Graziano PA, Kuriyan AB, Coxe S, Pelham WE, Rodriguez L, et al. Parent-teen behavior therapy + motivational interviewing for adolescents with ADHD. J Consult Clin Psychol. 2016;84(8):699–712.PubMedPubMedCentralCrossRef
18.
Evans SW, Schultz BK, Demars CE, Davis H. Effectiveness of the challenging horizons after-school program for young adolescents with ADHD. Behav Ther. 2011;42(3):462–74.PubMedPubMedCentralCrossRef
19.
Evans SW, Langberg JM, Schultz BK, Vaughn A, Altaye M, Marshall SA, et al. Evaluation of a school-based treatment program for young adolescents with ADHD. J Consult Clin Psychol. 2016;84(1):15–30.PubMedCrossRef
20.
Langberg JM, Vaughn AJ, Williamson P, Epstein JN, Girio-Herrera E, Becker SP. Refinement of an organizational skills intervention for adolescents with ADHD for implementation by school mental health providers. School Ment Health. 2011;3(3):143–55.PubMedPubMedCentralCrossRef
21.
Langberg JM, Epstein JN, Becker SP, Girio-Herrera E, Vaughn AJ. Evaluation of the homework, organization, and planning skills (HOPS) intervention for middle school students with ADHD as implemented by school mental health providers. School Psych Rev. 2012;41(3):342–64.PubMedPubMedCentralCrossRef
22.
Sibley MH, Pelham WE Jr, Derefinko KJ, Kuriyan AB, Sanchez F, Graziano PA. A pilot trial of supporting teens’ academic needs daily (STAND): a parent-adolescent collaborative intervention for ADHD. J Psychopathol Behav Assess. 2013;35(4):436–49.CrossRef
23.
Safren SA, Otto MW, Sprich S, Winett CL, Wilens TE, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther. 2005;43(7):831–42.PubMedCrossRef
24.
Boyer BE, Geurts HM, Prins PJ, Van der Oord S. Two novel CBTs for adolescents with ADHD: the value of planning skills. Eur Child Adolesc Psychiatry. 2015;24(9):1075–90.PubMedCrossRef
25.
Vidal R, Castells J, Richarte V, Palomar G, Garcia M, Nicolau R, et al. Group therapy for adolescents with attention-deficit/hyperactivity disorder: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry. 2015;54(4):275–82.PubMedCrossRef
26.
Jensen PS, Hinshaw SP, Kraemer HC, Lenora N, Newcorn JH, Abikoff HB, et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. J Am Acad Child Adolesc Psychiatry. 2001;40(2):147–58.PubMedCrossRef
27.
Banaschewski T, Becker K, Döpfner M, Holtmann M, Rösler M, Romanos M. Attention-deficit/hyperactivity disorder. Dtsch Arztebl Int. 2017;114(9):149–59.PubMedPubMedCentral
28.
Young S, Bramham J. Cognitive-Behavioural Therapy for ADHD in adolescents and adults- a psychological guide to practice. 2nd. ed. West Sussex: Wiley-Blackwell; 2012. p. 328.CrossRef
29.
Bramham J, Young S, Bickerdike A, Spain D, McCartan D, Xenitidis K. Evaluation of group cognitive behavioral therapy for adults with ADHD. J Atten Disord. 2009;12(5):434–41.PubMedCrossRef
30.
Novik TS, Haugan AJ, Lydersen S, Thomsen PH, Young S, Sund AM. Cognitive-behavioural group therapy for adolescents with ADHD: study protocol for a randomised controlled trial. BMJ Open. 2020;10(3):e032839.PubMedPubMedCentralCrossRef
31.
Shaffer D, Gould MS, Brasic J, Ambrosini P, Fisher P, Bird H, et al. A children's global assessment scale (CGAS). Arch Gen Psychiatry. 1983;40(11):1228–31.PubMedCrossRef
32.
Clinical GW, Impression G. ECDEU assessment manual for psychopharmacology, revised. Rockville: National Institute of Mental Health; 1976.
33.
World Health Organization. ICD-10 : international statistical classification of diseases and related health problems : tenth revision. 2nd ed. Geneva: World Health Organization; 1992.
34.
Kaufman J, Birmaher B, Brent D, Rao UMA, Flynn C, Moreci P, et al. Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): initial reliability and validity data. J Am Acad Child Adolesc Psychiatry. 1997;36(7):980–8.PubMedCrossRef
35.
Wechsler D. Wechsler intelligence scale for children- fourth edition (WISC-IV). San Antonio: The Psychological Corporation; 2003.
36.
Wechsler D. Wechsler Adult Intelligence Scale–Fourth Edition (WAIS-IV). San Antonio: Pearson; 2008.
37.
DuPaul GJ, Reid R, Anastopoulos AD, Lambert MC, Watkins MW, Power TJ. Parent and teacher ratings of attention-deficit/hyperactivity disorder symptoms: factor structure and normative data. Psychol Assessment. 2016;28(2):214–25.CrossRef
38.
39.
Bjaastad JF, Haugland BS, Fjermestad KW, Torsheim T, Havik OE, Heiervang ER, et al. Competence and adherence scale for cognitive behavioral therapy (CAS-CBT) for anxiety disorders in youth: psychometric properties. Psychol Assess. 2016;28(8):908–16.PubMedCrossRef
40.
DuPaul GJ, Anastopoulos AD, Power TJ, Reid R, Ikeda MJ, McGoey KE. Parent ratings of attention-deficit/hyperactivity disorder symptoms: factor structure and normative data. J Psychopathol Behav Assess. 1998;20(1):83–102.CrossRef
41.
Dopfner M, Steinhausen HC, Coghill D, Dalsgaard S, Poole L, Ralston SJ, et al. Cross-cultural reliability and validity of ADHD assessed by the ADHD rating scale in a pan-European study. Eur Child Adolesc Psychiatry. 2006;15(Suppl 1):I46–55.PubMedCrossRef
42.
Jozefiak T, Hanssen-Bauer K, Bjelland I. Måleegenskaper ved den norske versjonen av Children’s Global Assessment Scale (CGAS). PsykTestBarn. 2018;1:3.
43.
44.
45.
Gioia GA, Isquith PK, Guy SC, Kenworthy L. Behavior rating inventory of executive function professional maual. Odessa: Psychological Assessment Resources; 2000.
46.
Egeland J, Fallmyr Ø. Confirmatory factor analysis of the behavior rating inventory of executive function (BRIEF): support for a distinction between emotional and behavioral regulation. Child Neuropsychol. 2010;16(4):326–37.PubMedCrossRef
47.
Gioia GA, Isquith PK, Retzlaff PD, Espy KA. Confirmatory factor analysis of the behavior rating inventory of executive function (BRIEF) in a clinical sample. Child Neuropsychol. 2002;8(4):249–57.PubMedCrossRef
48.
Fallmyr O, Egeland J. Psychometric properties of the Norwegian version of BRIEF-for children from 5 to 18 years old. Tidsskrift for Norsk psykologforening. 2011;48(4):339–43.
49.
Birmaher B, Khetarpal S, Brent D, Cully M, Balach L, Kaufman J, et al. The screen for child anxiety related emotional disorders (SCARED): scale construction and psychometric characteristics. J Am Acad Child Adolesc Psychiatry. 1997;36(4):545–53.PubMedCrossRef
50.
Rappaport BI, Pagliaccio D, Pine DS, Klein DN, Jarcho JM. Discriminant validity, diagnostic utility, and parent-child agreement on the screen for child anxiety related emotional disorders (SCARED) in treatment- and non-treatment-seeking youth. J Anxiety Disord. 2017;51:22–31.PubMedPubMedCentralCrossRef
51.
52.
Angold A, Costello EJ, Messer SC, Pickles A, Winder F, Silver D. Development of a short questionnaire for use in epidemiological studies of depression in children and adolescents. Int J Methods Psychiatr Res. 1995;5:237–49.
53.
Jarbin H, Ivarsson T, Andersson M, Bergman H, Skarphedinsson G. Screening efficiency of the mood and feelings questionnaire (MFQ) and short mood and feelings questionnaire (SMFQ) in Swedish help seeking outpatients. PLoS One. 2020;15(3):e0230623.PubMedPubMedCentralCrossRef
54.
Larsson B, Ingul J, Jozefiak T, Leikanger E, Sund AM. Prevalence, stability, 1-year incidence and predictors of depressive symptoms among Norwegian adolescents in the general population as measured by the short mood and feelings questionnaire. Nord J Psychiatry. 2016;70(4):290–6.PubMedCrossRef
55.
Schwarzer R, Jerusalem M. Generalized self-efficacy scale. In: Extreme stress and communitites: measures in health psychology: a user’s portfolio causal and control beliefs. Windsor: NFER-NELSON; 1995. p. 159–77.
56.
Scholz U, Doña BG, Sud S, Schwarzer R. Is general self-efficacy a universal construct?1. Eur J Psychol Assess. 2002;18(3):242–51.CrossRef
57.
Luszczynska A, Scholz U, Schwarzer R. The general self-efficacy scale: multicultural validation studies. J Psychol. 2005;139(5):439–57.PubMedCrossRef
58.
Rosenberg M. Society and the adolescent self-image. Princeton: Princeton University Press; 1965.CrossRef
59.
Eklund M, Bäckström M, Hansson L. Psychometric evaluation of the Swedish version of Rosenberg's self-esteem scale. Nord J Psychiatry. 2018;72(5):318–24.PubMedCrossRef
60.
LeBourgeois MK, Giannotti F, Cortesi F, Wolfson AR, Harsh J. The relationship between reported sleep quality and sleep hygiene in Italian and American adolescents. Pediatrics. 2005;115(1 Suppl):257–65.PubMedCrossRef
61.
Huber NL, Nicoletta A, Ellis JM, Everhart DE. Validating the adolescent sleep wake scale for use with young adults. Sleep Med. 2020;69:217–9.PubMedCrossRef
62.
Coghill D, Seth S. Effective management of attention-deficit/hyperactivity disorder (ADHD) through structured re-assessment: the Dundee ADHD Clinical care pathway. Child Adolesc Psychiatry Ment Health. 2015;9:52.PubMedPubMedCentralCrossRef
63.
Twisk J, Bosman L, Hoekstra T, Rijnhart J, Welten M, Heymans M. Different ways to estimate treatment effects in randomised controlled trials. Contemp Clin Trials Commun. 2018;10:80–5.CrossRef
64.
Gewandter JS, McDermott MP, Kitt RA, Chaudari J, Koch JG, Evans SR, et al. Interpretation of CIs in clinical trials with non-significant results: systematic review and recommendations. BMJ Open. 2017;7(7):e017288.PubMedPubMedCentralCrossRef
65.
Steele M, Jensen PS, Quinn DM. Remission versus response as the goal of therapy in ADHD: a new standard for the field? Clin Ther. 2006;28(11):1892–908.PubMedCrossRef
66.
Brown RT, Borden KA, Wynne ME, Schleser R, Clingerman SR. Methylphenidate and cognitive therapy with ADD children: a methodological reconsideration. J Abnorm Child Psychol. 1986;14(4):481–97.PubMedCrossRef
67.
Meyer J, Ramklint M, Hallerbäck MU, Lööf M, Isaksson J. Evaluation of a structured skills training group for adolescents with attention-deficit/hyperactivity disorder: a randomised controlled trial. Eur Child Adolesc Psychiatry. 2021. https://​doi.​org/​10.​1007/​s00787-021-01753-2. Epub ahead of print. PMID: 33721085..
68.
Buitelaar JK. Optimising treatment strategies for ADHD in adolescence to minimise ‘lost in transition’ to adulthood. Eur Child Adolesc. 2017;26(5):448–52.
69.
Miller WR, Rollnick S. Motivational interviewing: Helping people change, vol. xii. 3rd ed. New York: Guilford Press; 2013. p. 482–xii.
70.
Buitelaar JK. Optimising treatment strategies for ADHD in adolescence to minimise 'lost in transition' to adulthood. Epidemiol Psychiatr Sci. 2017;26(5):448–52.PubMedPubMedCentralCrossRef
71.
72.
Sibley MH, Rodriguez L, Coxe S, Page T, Espinal K. Parent-teen group versus dyadic treatment for adolescent ADHD: what works for whom? J Clin Child Adolesc Psychol. 2020;49(4):476–92.PubMedCrossRef
73.
Emilsson B, Gudjonsson G, Sigurdsson JF, Baldursson G, Einarsson E, Olafsdottir H, et al. Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. BMC psychiatry. 2011;11:116.PubMedPubMedCentralCrossRef
74.
Larsson H, Sariaslan A, Långström N, D'Onofrio B, Lichtenstein P. Family income in early childhood and subsequent attention deficit/hyperactivity disorder: a quasi-experimental study. J Child Psychol Psychiatry. 2014;55(5):428–35.PubMedCrossRef
75.
Østergaard SD, Larsen JT, Dalsgaard S, Wilens TE, Mortensen PB, Agerbo E, et al. Predicting ADHD by assessment of Rutter's indicators of adversity in infancy. PLoS One. 2016;11(6):e0157352.PubMedPubMedCentralCrossRef
76.
77.
Nøvik TS, Hervas A, Ralston** SJ, Dalsgaard S, Rodrigues Pereira R, Lorenzo MJ, et al. Influence of gender on attention-deficit/hyperactivity disorder in Europe – ADORE. Eur Child Adolesc Psychiatry 2006;15(1):i15-i24.
78.
Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Bmj. 2010;340:c869.PubMedPubMedCentralCrossRef
Metadata
Title
Cognitive behavioural group therapy as addition to psychoeducation and pharmacological treatment for adolescents with ADHD symptoms and related impairments: a randomised controlled trial
Authors
Anne-Lise Juul Haugan
Anne Mari Sund
Susan Young
Per Hove Thomsen
Stian Lydersen
Torunn Stene Nøvik
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2022
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/s12888-022-04019-6

Other articles of this Issue 1/2022

BMC Psychiatry 1/2022 Go to the issue

Research

Exploring risk factors for re-hospitalization in a psychiatric inpatient setting: a retrospective naturalistic study

Research

Psychiatric patients’ attitudes towards being hospitalized: a national multicentre study in Norway

Research

Late-manifestation of attention-deficit/hyperactivity disorder in older adults: an observational study

Research

Psychometric properties of the Persian version of short-form five factor borderline inventory (FFBI-SF)

Research

Community suicide rates and related factors within a surveillance platform in Western Kenya

Research

Adversity coping capability and its associations with mental health and family wellbeing amid the COVID-19 pandemic in Hong Kong